Ningyan Zhang

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 38

Top Venues

Nature communications

Cancer immunology research

NPJ vaccines

Kidney360

University of Kentucky (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Kentucky

United States

PHD

Publications

Ryan Huang, Xiaoye Liu, Jaehyup Kim, Hui Deng, Mi Deng, Xun Gui, Heyu Chen, Guojin Wu, Wei Xiong, Jingjing Xie, Cheryl M Lewis, Jade Homsi, Xing Yang, Chengcheng Zhang, Yubo He, Qi Lou, Caroline Smith, Samuel John, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development. Cancer immunology research 12 (3) (2024)
Ryan Huang, Xiaoye Liu, Jaehyup Kim, Hui Deng, Mi Deng, Xun Gui, Heyu Chen, Guojin Wu, Wei Xiong, Jingjing Xie, Cheryl M Lewis, Jade Homsi, Xing Yang, Chengcheng Zhang, Yubo He, Qi Lou, Caroline Smith, Samuel John, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development. Cancer immunology research 12 (3) (2024)
Xiaohua Ye, David J H Shih, Zhiqiang Ku, Junping Hong, Diane F Barrett, Richard E Rupp, Ningyan Zhang, Tong-Ming Fu, W Jim Zheng, Zhiqiang An
Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccine. NPJ vaccines 9 (1) (2024)
Alexander H Flannery, Dawei Bu, Madison Botkins, Fabiola Gianella, Ningyan Zhang, Zhiqiang An, Orson W Moe, Jan-Bernd Funcke, Javier A Neyra
Endotrophin as a Biomarker for Severe Acute Kidney Injury and Major Adverse Kidney Events. Kidney360 5 (8) (2024)
Xiaohua Ye, David J H Shih, Zhiqiang Ku, Junping Hong, Diane F Barrett, Richard E Rupp, Ningyan Zhang, Tong-Ming Fu, W Jim Zheng, Zhiqiang An
Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccine. NPJ vaccines 9 (1) (2024)
Alexander H Flannery, Dawei Bu, Madison Botkins, Fabiola Gianella, Ningyan Zhang, Zhiqiang An, Orson W Moe, Jan-Bernd Funcke, Javier A Neyra
Endotrophin as a Biomarker for Severe Acute Kidney Injury and Major Adverse Kidney Events. Kidney360 5 (8) (2024)
Alexander H Flannery, Dawei Bu, Madison Botkins, Fabiola Gianella, Ningyan Zhang, Zhiqiang An, Orson W Moe, Jan-Bernd Funcke, Javier A Neyra
Endotrophin as a Biomarker for Severe Acute Kidney Injury and Major Adverse Kidney Events. Kidney360 (2024)
Ryan Huang, Xiaoye Liu, Jaehyup Kim, Hui Deng, Mi Deng, Xun Gui, Heyu Chen, Guojin Wu, Wei Xiong, Jingjing Xie, Cheryl M Lewis, Jade Homsi, Xing Yang, Chengcheng Zhang, Yubo He, Qi Lou, Caroline Smith, Samuel John, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development. Cancer immunology research 12 (3) (2024)
Ryan Huang, Xiaoye Liu, Jaehyup Kim, Hui Deng, Mi Deng, Xun Gui, Heyu Chen, Guojin Wu, Wei Xiong, Jingjing Xie, Cheryl M Lewis, Jade Homsi, Xing Yang, Chengcheng Zhang, Yubo He, Qi Lou, Caroline Smith, Samuel John, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development. Cancer immunology research 12 (3) (2024)
Xiaohua Ye, David J H Shih, Zhiqiang Ku, Junping Hong, Diane F Barrett, Richard E Rupp, Ningyan Zhang, Tong-Ming Fu, W Jim Zheng, Zhiqiang An
Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccine. NPJ vaccines 9 (1) (2024)
Ryan Huang, Xiaoye Liu, Jaehyup Kim, Hui Deng, Mi Deng, Xun Gui, Heyu Chen, Guojin Wu, Wei Xiong, Jingjing Xie, Cheryl M Lewis, Jade Homsi, Xing Yang, Chengcheng Zhang, Yubo He, Qi Lou, Caroline Smith, Samuel John, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang
LILRB3 Supports Immunosuppressive Activity of Myeloid Cells and Tumor Development. Cancer immunology research 12 (3) (2024)
Christopher J LaFargue, Paola Amero, Kyunghee Noh, Lingegowda S Mangala, Yunfei Wen, Emine Bayraktar, Sujanitha Umamaheswaran, Elaine Stur, Santosh K Dasari, Cristina Ivan, Sunila Pradeep, Wonbeak Yoo, Chunhua Lu, Nicholas B Jennings, Vinod Vathipadiekal, Wei Hu, Anca Chelariu-Raicu, Zhiqiang Ku, Hui Deng, Wei Xiong, Hyun-Jin Choi, Min Hu, Takae Kiyama, Chai-An Mao, Rouba Ali-Fehmi, Michael J Birrer, Jinsong Liu, Ningyan Zhang, Gabriel Lopez-Berestein, Vittorio de Franciscis, Zhiqiang An, Anil K Sood
Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L. Nature communications 14 (1) (2023)
Christopher J LaFargue, Paola Amero, Kyunghee Noh, Lingegowda S Mangala, Yunfei Wen, Emine Bayraktar, Sujanitha Umamaheswaran, Elaine Stur, Santosh K Dasari, Cristina Ivan, Sunila Pradeep, Wonbeak Yoo, Chunhua Lu, Nicholas B Jennings, Vinod Vathipadiekal, Wei Hu, Anca Chelariu-Raicu, Zhiqiang Ku, Hui Deng, Wei Xiong, Hyun-Jin Choi, Min Hu, Takae Kiyama, Chai-An Mao, Rouba Ali-Fehmi, Michael J Birrer, Jinsong Liu, Ningyan Zhang, Gabriel Lopez-Berestein, Vittorio de Franciscis, Zhiqiang An, Anil K Sood
Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L. Nature communications 14 (1) (2023)
Sarah M Valencia, Eric Rochat, Melissa J Harnois, Maria Dennis, Helen S Webster, Bhavna Hora, Amit Kumar, Hsuan-Yuan Sherry Wang, Leike Li, Daniel Freed, Ningyan Zhang, Zhiqiang An, Dai Wang, Sallie R Permar
Vaccination with a replication-defective cytomegalovirus vaccine elicits a glycoprotein B-specific monoclonal antibody repertoire distinct from natural infection. NPJ vaccines 8 (1) (2023)
Shangang Zhao, Qian Lin, Wei Xiong, Li Li, Leon G Straub, Dinghong Zhang, Rizaldy C Zapata, Qingzhang Zhu, Xue-Nan Sun, Zhuzhen Zhang, Jan-Bernd Funcke, Chao Li, Shiuhwei Chen, Yi Zhu, Nisi Jiang, Guannan Li, Ziying Xu, Steven C Wyler, May-Yun Wang, Juli Bai, Xianlin Han, Christine M Kusminski, Ningyan Zhang, Zhiqiang An, Joel K Elmquist, Olivia Osborn, Chen Liu, Jan-Bernd Funcke
Hyperleptinemia contributes to antipsychotic drug-associated obesity and metabolic disorders. Science translational medicine 15 (723) (2023)
Christopher J LaFargue, Paola Amero, Kyunghee Noh, Lingegowda S Mangala, Yunfei Wen, Emine Bayraktar, Sujanitha Umamaheswaran, Elaine Stur, Santosh K Dasari, Cristina Ivan, Sunila Pradeep, Wonbeak Yoo, Chunhua Lu, Nicholas B Jennings, Vinod Vathipadiekal, Wei Hu, Anca Chelariu-Raicu, Zhiqiang Ku, Hui Deng, Wei Xiong, Hyun-Jin Choi, Min Hu, Takae Kiyama, Chai-An Mao, Rouba Ali-Fehmi, Michael J Birrer, Jinsong Liu, Ningyan Zhang, Gabriel Lopez-Berestein, Vittorio de Franciscis, Zhiqiang An, Anil K Sood
Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L. Nature communications 14 (1) (2023)
Christopher J LaFargue, Paola Amero, Kyunghee Noh, Lingegowda S Mangala, Yunfei Wen, Emine Bayraktar, Sujanitha Umamaheswaran, Elaine Stur, Santosh K Dasari, Cristina Ivan, Sunila Pradeep, Wonbeak Yoo, Chunhua Lu, Nicholas B Jennings, Vinod Vathipadiekal, Wei Hu, Anca Chelariu-Raicu, Zhiqiang Ku, Hui Deng, Wei Xiong, Hyun-Jin Choi, Min Hu, Takae Kiyama, Chai-An Mao, Rouba Ali-Fehmi, Michael J Birrer, Jinsong Liu, Ningyan Zhang, Gabriel Lopez-Berestein, Vittorio de Franciscis, Zhiqiang An, Anil K Sood
Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L. Nature communications 14 (1) (2023)
Ryan Huang, Xiaoye Liu, Jaehyup Kim, Hui Deng, Mi Deng, Xun Gui, Heyu Chen, Guojin Wu, Wei Xiong, Jingjing Xie, Cheryl M Lewis, Jade Homsi, Xing Yang, Chengcheng Zhang, Yubo He, Qi Lou, Caroline Smith, Samuel John, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang
LILRB3 supports immunosuppressive activity of myeloid cells and tumor development. Cancer immunology research (2023)
Christopher J LaFargue, Paola Amero, Kyunghee Noh, Lingegowda S Mangala, Yunfei Wen, Emine Bayraktar, Sujanitha Umamaheswaran, Elaine Stur, Santosh K Dasari, Cristina Ivan, Sunila Pradeep, Wonbeak Yoo, Chunhua Lu, Nicholas B Jennings, Vinod Vathipadiekal, Wei Hu, Anca Chelariu-Raicu, Zhiqiang Ku, Hui Deng, Wei Xiong, Hyun-Jin Choi, Min Hu, Takae Kiyama, Chai-An Mao, Rouba Ali-Fehmi, Michael J Birrer, Jinsong Liu, Ningyan Zhang, Gabriel Lopez-Berestein, Vittorio de Franciscis, Zhiqiang An, Anil K Sood
Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L. Nature communications 14 (1) (2023)
Zhiqiang Ku, Xuping Xie, Jian Qing Lin, Peng Gao, Bin Wu, Abbas El Sahili, Hang Su, Yang Liu, Xiaohua Ye, Eddie Yongjun Tan, Xin Li, Xuejun Fan, Boon Chong Goh, Wei Xiong, Hannah Boyd, Antonio E Muruato, Hui Deng, Hongjie Xia, Jing Zou, Birte K Kalveram, Vineet D Menachery, Ningyan Zhang, Julien Lescar, Pei-Yong Shi, Zhiqiang An
Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth. Nature communications 13 (1) (2022)
Summer Y Y Ha, Yasuaki Anami, Chisato M Yamazaki, Wei Xiong, Candice M Haase, Scott D Olson, Jangsoon Lee, Naoto Tada Ueno, Ningyan Zhang, Zhiqiang An, Kyoji Tsuchikama
An Enzymatically Cleavable Tripeptide Linker for Maximizing the Therapeutic Index of Antibody-Drug Conjugates. Molecular cancer therapeutics 21 (9) (2022)
Xuejun Fan, Zihao Yuan, Yueshui Zhao, Wei Xiong, Hao-Ching Hsiao, Rahmawati Pare, Jianmin Ding, Ahmad Almosa, Kai Sun, Songlin Zhang, Robert E Jordan, Cheok Song Lee, Zhiqiang An, Ningyan Zhang
Impairment of IgG Fc functions promotes tumor progression and suppresses NK cell antitumor actions. Communications biology 5 (1) (2022)
Peng Zhao, Yuanzhong Xu, Lu-Lin Jiang, Xuejun Fan, Leike Li, Xin Li, Hisashi Arase, Yingjun Zhao, Wei Cao, Hui Zheng, Huaxi Xu, Qingchun Tong, Ningyan Zhang, Zhiqiang An
A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer's disease. Science translational medicine 14 (661) (2022)
Daniel Wrapp, Xiaohua Ye, Zhiqiang Ku, Hang Su, Harrison G Jones, Nianshuang Wang, Akaash K Mishra, Daniel C Freed, Fengsheng Li, Aimin Tang, Leike Li, Dabbu Kumar Jaijyan, Hua Zhu, Dai Wang, Tong Ming Fu, Ningyan Zhang, Zhiqiang An, Jason S Mclellan
Structural basis for HCMV Pentamer recognition by neuropilin 2 and neutralizing antibodies. Science advances 8 (10) (2022)
Yasuaki Anami, Wei Xiong, Aiko Yamaguchi, Chisato M Yamazaki, Ningyan Zhang, Zhiqiang An, Kyoji Tsuchikama
Homogeneous antibody-angiopep 2 conjugates for effective brain targeting. RSC advances 12 (6) (2022)
Guojin Wu, Yixiang Xu, Robbie D Schultz, Heyu Chen, Jingjing Xie, Mi Deng, Xiaoye Liu, Xun Gui, Samuel John, Zhigang Lu, Hisashi Arase, Ningyan Zhang, Zhiqiang An, Cheng Cheng Zhang
LILRB3 supports acute myeloid leukemia development and regulates T-cell antitumor immune responses through the TRAF2-cFLIP-NF-κB signaling axis. Nature cancer 2 (11) (2021)
Zhiqiang Ku, Xuping Xie, Edgar Davidson, Xiaohua Ye, Hang Su, Vineet D Menachery, Yize Li, Zihao Yuan, Xianwen Zhang, Antonio E Muruato, Ariadna Grinyo I Escuer, Breanna Tyrell, Kyle Doolan, Benjamin J Doranz, Daniel Wrapp, Paul F Bates, Jason S Mclellan, Susan R Weiss, Ningyan Zhang, Pei-Yong Shi, Zhiqiang An
Author Correction: Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape. Nature communications 12 (1) (2021)
Chisato M Yamazaki, Aiko Yamaguchi, Yasuaki Anami, Wei Xiong, Yoshihiro Otani, Jangsoon Lee, Naoto Tada Ueno, Ningyan Zhang, Zhiqiang An, Kyoji Tsuchikama
Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance. Nature communications 12 (1) (2021)
Anjali Geethadevi, Bindu Nair, Deepak Parashar, Zhiqiang Ku, Wei Xiong, Hui Deng, Yongsheng Li, Jasmine George, Donna M McAllister, Yunguang Sun, Ishaque P Kadamberi, Prachi Gupta, Michael B Dwinell, William H Bradley, Janet S Rader, Hallgeir Rui, Robert F Schwabe, Ningyan Zhang, Sunila Pradeep, Zhiqiang An, Pradeep Chaluvally-Raghavan
Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian Cancer Growth. Cancer research 81 (20) (2021)
Xiujie Sun, Bogang Wu, Huai-Chin Chiang, Hui Deng, Xiaowen Zhang, Wei Xiong, Junquan Liu, Aaron M Rozeboom, Brent T Harris, Eline Blommaert, Antonio Gómez, Roderic Espin Garcia, Yufan Zhou, Payal Mitra, Madeleine Prevost, Deyi Zhang, Debarati Banik, Claudine Isaacs, Deborah Berry, Catherine Lai, Krysta Chaldekas, Patricia S Latham, Christine A Brantner, Anastas Popratiloff, Victor X Jin, Ningyan Zhang, Yanfen Hu, Miguel Angel Pujana, Tyler J Curiel, Zhiqiang An, Rong Li
Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion. Nature 599 (7886) (2021)
Hang Su, Xiaohua Ye, Daniel C Freed, Leike Li, Zhiqiang Ku, Wei Xiong, Peng Gao, Xinli Liu, Diana Montgomery, Weifeng Xu, Amy S Espeseth, Dai Wang, Ningning Ma, Tong-Ming Fu, Ningyan Zhang, Zhiqiang An
Potent Bispecific Neutralizing Antibody Targeting Glycoprotein B and the gH/gL/pUL128/130/131 Complex of Human Cytomegalovirus. Antimicrobial agents and chemotherapy 65 (3) (2021)
Zhiqiang Ku, Xuping Xie, Paul R Hinton, Xinli Liu, Xiaohua Ye, Antonio E Muruato, Dean C Ng, Sujit Biswas, Jing Zou, Yang Liu, Deepal Pandya, Vineet D Menachery, Sachi Rahman, Yu-An Cao, Hui Deng, Wei Xiong, Kevin B Carlin, Junquan Liu, Hang Su, Elizabeth J Haanes, Bruce A Keyt, Ningyan Zhang, Stephen F Carroll, Pei-Yong Shi, Zhiqiang An
Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants. Nature 595 (7869) (2021)
Zhiqiang Ku, Xuping Xie, Edgar Davidson, Xiaohua Ye, Hang Su, Vineet D Menachery, Yize Li, Zihao Yuan, Xianwen Zhang, Antonio E Muruato, Ariadna Grinyo I Escuer, Breanna Tyrell, Kyle Doolan, Benjamin J Doranz, Daniel Wrapp, Paul F Bates, Jason S Mclellan, Susan R Weiss, Ningyan Zhang, Pei-Yong Shi, Zhiqiang An
Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape. Nature communications 12 (1) (2021)
Leike Li, Daniel C Freed, Yaping Liu, Fengsheng Li, Diane F Barrett, Wei Xiong, Xiaohua Ye, Stuart P Adler, Richard E Rupp, Dai Wang, Ningyan Zhang, Tong-Ming Fu, Zhiqiang An
A conditionally replication-defective cytomegalovirus vaccine elicits potent and diverse functional monoclonal antibodies in a phase I clinical trial. NPJ vaccines 6 (1) (2021)
Zihao Yuan, Xuejun Fan, Jay-Jiguang Zhu, Tong Ming Fu, Jiaqian Wu, Hua Xu, Ningyan Zhang, Zhiqiang An, Wenjin Jim Zheng
Presence of complete murine viral genome sequences in patient-derived xenografts. Nature communications 12 (1) (2021)
Yasuaki Anami, Mi Deng, Xun Gui, Aiko Yamaguchi, Chisato M Yamazaki, Ningyan Zhang, Zhiqiang An, Kyoji Tsuchikama
LILRB4-targeting Antibody-Drug Conjugates for the Treatment of Acute Myeloid Leukemia. Molecular cancer therapeutics 19 (11) (2020)
Xiaohua Ye, Hang Su, Daniel Wrapp, Daniel C Freed, Fengsheng Li, Zihao Yuan, Aimin Tang, Leike Li, Zhiqiang Ku, Wei Xiong, Dabbu Jaijyan, Hua Zhu, Dai Wang, Jason S Mclellan, Ningyan Zhang, Tong Ming Fu, Zhiqiang An
Recognition of a highly conserved glycoprotein B epitope by a bivalent antibody neutralizing HCMV at a post-attachment step. PLoS pathogens 16 (8) (2020)
Leike Li, Weixu Meng, Melanie Horton, Daniel R DiStefano, Elizabeth A Thoryk, Jennifer M Pfaff, Qihui Wang, Georgina T Salazar, Trevor Barnes, Benjamin J Doranz, Andrew J Bett, Danilo R Casimiro, Kalpit A Vora, Zhiqiang An, Ningyan Zhang
Potent neutralizing antibodies elicited by dengue vaccine in rhesus macaque target diverse epitopes. PLoS pathogens 15 (6) (2019)

Ningyan Zhang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ningyan Zhang